KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ:TRVN), a clinical stage pharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors (GPCRs), today announced that the Company will present four posters at PAINWeek®, the National Conference on Pain for Frontline Practitioners, being held at The Cosmopolitan Las Vegas, in Las Vegas, NV from September 8 – 12, 2015.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
